Scott Koenig
2013
In 2013, Scott Koenig earned a total compensation of $3.3M as President, Chief Executive Officer and Director at MacroGenics, a 312% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $275,000 |
---|---|
Option Awards | $2,520,820 |
Salary | $456,065 |
Other | $3,825 |
Total | $3,255,720 |
Koenig received $2.5M in option awards, accounting for 77% of the total pay in 2013.
Koenig also received $275K in non-equity incentive plan, $456.1K in salary and $3.8K in other compensation.
Rankings
In 2013, Scott Koenig's compensation ranked 2,308th out of 12,286 executives tracked by ExecPay. In other words, Koenig earned more than 81.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,308 out of 12,286 | 81st |
Division Manufacturing | 764 out of 4,612 | 83rd |
Major group Chemicals And Allied Products | 208 out of 1,462 | 86th |
Industry group Drugs | 139 out of 1,156 | 88th |
Industry Pharmaceutical Preparations | 117 out of 890 | 87th |
Source: SEC filing on April 7, 2016.
Koenig's colleagues
We found three more compensation records of executives who worked with Scott Koenig at MacroGenics in 2013.
News
MacroGenics CEO Scott Koenig's 2023 pay slips 20% to $3.7M
April 8, 2024
MacroGenics CEO Scott Koenig's 2022 pay slips 5% to $4.6M
April 17, 2023
MacroGenics CEO Scott Koenig's 2021 pay jumps 56% to $4.9M
April 8, 2022
MacroGenics Chief Medical Officer Stephen Eck receives $5.1M in 2020
April 1, 2021
MacroGenics CEO Scott Koenig's 2019 pay slips 9% to $4.7M
April 2, 2020